All India Organisation of Chemists and Druggists (AIOCD)’s call for a 24-hour nationwide ‘Pharma Bandh’ on May 20, 2026.
On May 20, 2026, the local pharmacies that serve as the first point of care for millions of Indian families will go dark. The...
Ayushman Arogya Mandirs, Digital Health & Inclusive NHM Progress Highlighted in 17th CRM Findings
The two-day 10th National Summit on Innovation and Inclusivity, organised under the National Health Mission (NHM), concluded with a strong emphasis on evidence-based reforms,...
Dr. Reddy’s Makes History with Health Canada Approval of World’s First Generic Semaglutide Injection in a G7 Market
Dr. Reddy’s Laboratories Ltd.a leading global pharmaceutical company, is pleased to announce it has received a Notice of Compliance (NOC) from Health Canada for...
Union Health Minister J. P. Nadda Reviews NIPER Mohali’s Innovation Pipeline, Inaugurates Medicinal Succulents Garden
Union Minister for Health and Family Welfare and Chemicals & Fertilizers, Shri J. P. Nadda, visited the National Institute of Pharmaceutical Education and Research...
Eli Lilly Expands Oncology Ambitions with Up to $2.3 Billion Ajax Therapeutics Acquisition
Eli Lilly has announced a major strategic move to strengthen its oncology portfolio through the acquisition of Ajax Therapeutics in a deal valued at...
Novartis Receives European Commission Approval for Rhapsido®, the First Oral Targeted Therapy for Chronic Spontaneous Urticaria
Novartis has officially received European Commission (EC) approval for Rhapsido® (remibrutinib), marking a historic shift in the management of chronic spontaneous urticaria (CSU). Rhapsido...